NXGLW
HealthcareNexgel Inc - Warrants (17/12/2026)
$0.06-0.01 (-9.24%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving NXGLW Today?
No stock-specific AI insight has been generated for NXGLW yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Market Cap$123,749.51
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding2.1M
NXGLW News
20 articles- NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of DirectorsYahoo Finance·May 6, 2026
- NEXGEL Appoints Ian Blackman as Chief Financial OfficerYahoo Finance·Apr 27, 2026
- NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease SegmentYahoo Finance·Apr 21, 2026
- Celularity Announces Closing of Transaction with NexGelYahoo Finance·Apr 21, 2026
- NEXGEL, Inc. Q4 2025 Earnings Call SummaryMoby·Apr 21, 2026
- NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ETGlobeNewswire Inc.·Apr 17, 2026
- NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity TransactionYahoo Finance·Apr 15, 2026
- NexGel Inc (NXGL) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Operational ...Yahoo Finance·Apr 9, 2026
- NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity TransactionYahoo Finance·Apr 8, 2026
- NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with CelularityYahoo Finance·Mar 31, 2026
- NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31stYahoo Finance·Mar 25, 2026
- NEXGEL to Report Third Quarter 2025 Financial Results on November 11thYahoo Finance·Nov 3, 2025
- NEXGEL to Present at the LD Micro Main Event XIX Conference on October 19-21Yahoo Finance·Oct 9, 2025
- NEXGEL, Inc. (NASDAQ:NXGL) Just Reported Earnings, And Analysts Cut Their Target PriceYahoo Finance·Aug 16, 2025
- NexGel Inc (NXGL) Q2 2025 Earnings Call Highlights: Revenue Doubles Amid Strategic Growth and ...Yahoo Finance·Aug 13, 2025
- NEXGEL Reports Second Quarter 2025 Financial ResultsYahoo Finance·Aug 12, 2025
- NEXGEL to Report Second Quarter 2025 Financial Results on August 12thYahoo Finance·Aug 6, 2025
- NEXGEL Appoints Chief Accounting Officer of Shutterstock, Steve Ciardiello, CPA, to its Board of DirectorsYahoo Finance·Aug 5, 2025
- NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private PlacementYahoo Finance·Aug 1, 2025
- NEXGEL and STADA AG Announce Expansion of Partnership for North AmericaYahoo Finance·Jul 14, 2025
All 20 articles loaded
Price Data
Open$0.00
Previous Close$0.07
Day High$0.00
Day Low$0.00
52 Week High—
52 Week Low—
Fundamentals
Market Cap$123,749.51
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding2.1M
About Nexgel Inc - Warrants (17/12/2026)
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
HealthcareSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Company Details
Security TypeStock
ExchangeNASDAQ
Currency—
Round Lot—
SICSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CIK—
Composite FIGI—
Share Class FIGI—